Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Child Neurology
•
Neurogenetics
What factors do you consider when determining eligibility for hematopoietic stem cell therapies for metachromatic leukodystrophy?
Related Questions
When do you consider cannabidiol for treatment of epilepsy?
When, if ever, do you use therapeutic hypothermia (targeted temperature management) in a non-neotal pediatric cardiac arrest patient?
What behavioral interventions have you found most effective for managing self-injurious behavior in autism?
Are there specific tools that you request for an IEP of a child with dyslexia?
When would you use memantine for autism spectrum disorder?
How do you counsel on the risks of developing anti-drug antibodies when using intrathecal enzyme replacement therapy for lysosomal storage disorders?
What criteria do you use to differentiate between MOGAD and MS in pediatric patients?
When is the most appropriate time to initiate evaluation for learning disorders following traumatic brain injury in an adolescent?
Do you use alcohol to trigger seizures in patients you suspect to have JME to confirm diagnosis?
When do you consider surgery for patients with Sturge Weber?
